In the publicly available GENIE dataset, looking exclusively at cutaneous melanomas shows that the specific mutation rates within primary tumors were 55 % for TERT, 40 % for BRAF, 7.2 % for KIT, 2.5 % for NRAS, and 1.9 % for CDH1. This evidence concerns the gene CDH1 and cutaneous melanoma.